Andrzej S. Krolewski, MD, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology

ALEXANDRIA, VA--(Marketwired - Apr 23, 2014) - The American Diabetes Association will present the Kelly West Award for Outstanding Achievement in Epidemiology to Andrzej S. Krolewski, MD, PhD. Supported by an unrestricted educational grant from Merck, this award is given to an individual who has made significant contributions to the field of diabetes epidemiology. Dr. Krolewski will be recognized with this honor at the Association's 74^th Scientific Sessions^®, taking place June 13-17, 2014, at the Moscone Center in San Francisco. 

Currently head of the Section of Genetics and Epidemiology at Joslin Diabetes Center and a professor of medicine at Harvard Medical School, Dr. Krolewski has advanced our understanding of diabetic nephropathy with research that uses epidemiology and new omics technologies. He has also trained more than 40 research fellows in genetic and epidemiologic approaches to studying the etiology of diabetes and its complications.

Dr. Krolewski's seminal 2003 report in The New England Journal of Medicine challenged the widely held belief that microalbuminuria is the first step on the path to end stage renal disease (ESRD). Subsequently he discovered that renal disease begins with early, progressive renal decline, a process independent of microalbuminuria, that starts when patients still have normal renal function. Recently, he also discovered that high serum concentrations of TNF receptor 1 and 2 are strong predictors of ESRD.

Dr. Boyko will give the Kelly West Award Lecture, "Time to Retire 'Microalbuminuria': Early, Progressive Renal Decline is the New Paradigm," on Sunday, June 15, at Scientific Sessions.

More than 14,000 top scientists, physicians and other health care professionals from around the world will share the latest cutting-edge research and learn the most up-to-date information on prevention, treatment and care, at the Association's Scientific Sessions taking place June 13-17, 2014. 

The American Diabetes Association is leading the fight to Stop Diabetes^® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Contact:
Madison Trimble
703-549-1500 ext. 2139
[e-mail]